Sign In
Buy AUSAF
$0.0001
+0 (+0%)
At Close: Jun 03, 2026
Australis Capital Inc and Copperstate Farms strike a major facility agreement
09:40am, Monday, 19'th Apr 2021
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) announced that through its majority-owned subsidiary ALPS, it has struck an agreement with Arizona's largest cannabis wholesaler, Copperstate
Australis finds its first chief science officer in University of Alberta lead cardiologist Jason Dyck
11:38am, Monday, 12'th Apr 2021
Australis Capital Inc (CSE:AUSA) (OTC:AUSAF) (FRA:AC4) has appointed Jason Dyck, director of the Cardiovascular Research Centre at the University of Alberta, as its new chief science officer and chair
Wall Street starts in the red
11:38am, Monday, 12'th Apr 2021
10.15am: Proactive North America headlines: Genprex Inc (NASDAQ:GNPX) presents positive preclinical data for lung cancer drug REQORSA at American Association for Cancer Research meeting Kintara Ther
Australis Capital completes first phase of Green Therapeutics acquisition with cannabis subsidiary purchase
10:00am, Wednesday, 24'th Mar 2021
Australis Capital Inc (CSE:AUSA) (OTC:AUSAF) (FRA:AC4) announced Wednesday that it has completed the first stage of its previously announced acquisition of Nevada cannabis company Green Therapeutics L
Australis' Accretive Acquisitions (Podcast Transcript)
11:03am, Sunday, 07'th Mar 2021
Australis Capital CFO Jon Paul joins the show to discuss closing its acquisitions and why coming on board was a bet on CEO Terry Booth. How MSOs will rationalize over time; optimism on banking opening
Australis' Accretive Acquisitions (Podcast)
08:00am, Wednesday, 03'rd Mar 2021
Australis' Accretive Acquisitions (Podcast)
US stocks mixed at open as traders look for direction
10:32am, Tuesday, 02'nd Mar 2021
10.25am: Proactive North America headlines: Tartisan Nickel Corp (CSE:TN) (OTCMKTS:TTSRF) (FRA:8TA) poised for geophysical survey at flagship Kenbridge nickel-copper-cobalt project Psyched Wellness Lt
Australis Capital looks ahead to "rapid growth" following two transformative acquisitions; ends 3Q with $7.6M cash
09:30am, Tuesday, 02'nd Mar 2021
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) reported its third quarter 2021 results on Monday evening that saw the company end a transformational period with $7.6 million in cash. Rev
US markets heading north at lunch as Fed chair's comments reassure traders
12:22pm, Wednesday, 24'th Feb 2021
US markets were heading higher at the midday point as investors watched more testimony from Fed Reserve chair Jerome Powell and basked in optimism over news that the FDA said Johnson & Johnson's coron
Australis Capital buys 51% stake in cannabis facility design/construction company ALPS
10:07am, Wednesday, 24'th Feb 2021
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) has reached a definitive agreement to acquire 51% of the issued and outstanding shares of cannabis facility design company ALPS, the company
Australis Capital scaling up its award-winning brands across the US and global cannabis markets
06:57am, Thursday, 11'th Feb 2021
Focused on building companies through early-stage, opportunistic, and diversified investments in cannabis space Spun off from Aurora Cannabis in late 2018 Terry Booth, who helped build Aurora, slated
Australis Capital says nearing completion of its acquisitions of ALPS and Green Therapeutics
12:10pm, Tuesday, 09'th Feb 2021
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) said Tuesday it is progressing well towards the completion of its proposed acquisitions of ALPS and Green Therapeutics LLC (GT). Australis is seeking
